Brief: Alzamend Neuro Granted Extension By Nasdaq Panel To Regain Compliance With The Minimum Bid Price Continued Listing Requirement
22/09/2023 13:08
Sept 22 (Reuters) - Alzamend Neuro Inc ALZN.O :
* ALZAMEND NEURO GRANTED EXTENSION BY NASDAQ PANEL TO REGAIN
COMPLIANCE WITH THE MINIMUM BID PRICE CONTINUED LISTING
REQUIREMENT
Source text for Eikon: ID:nBw21LtCca
Further company coverage: ALZN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview